Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling

被引:0
|
作者
Marleen Decruyenaere
Gerry Evers-Kiebooms
Lieve Denayer
Myriam Welkenhuysen
Erna Claes
Eric Legius
Koen Demyttenaere
机构
[1] Centre for Human Genetics,Department of Psychiatry
[2] University of Leuven,undefined
[3] University of Leuven,undefined
来源
关键词
Hereditary breast and ovarian cancer; BRCA1; BRCA2; predictive testing; genetic counselling; psychological aspects;
D O I
暂无
中图分类号
学科分类号
摘要
Since the identification of two breast–ovarian cancer susceptibility genes (BRCA1/2), predictive testing for hereditary breast/ovarian cancer (HBOC) has been available. Given the complexity and uncertainties of HBOC and the potential impact of predictive testing on psychological well-being, we offer the test applicants a combination of information-oriented and psychological counselling. In this paper, we describe the multidisciplinary approach for predictive testing for HBOC as a clinical service in Leuven, hereby focusing on psychological and decision counselling practice. Attention is paid to the theoretical framework used for pre-test psychological counselling in Leuven. We discuss three important interacting dimensions of psychological counselling: individual emotional support, decision counselling and support of the family communication process. Decision counselling consists of an evaluation of the cognitive and the emotional processing of the information given and strategies and resources for coping. This serves as a starting point to facilitate free informed decision making. Scenario development is used as a decision aid.
引用
收藏
页码:130 / 136
页数:6
相关论文
共 50 条
  • [31] The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample
    Caruso, Anita
    Vigna, Cristina
    Maggi, Gabriella
    Sega, Fabio Massimo
    Cognetti, Francesco
    Savarese, Antonella
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2008, 27 (1)
  • [32] CARE OF PATIENT WITH MINIMAL BREAST-CANCER - PRE-TEST AND POST-TEST
    JELENKO, C
    AMERICAN SURGEON, 1978, 44 (09) : 614 - 616
  • [33] Genetic testing for hereditary breast and ovarian cancer: Responsibility and choice
    d'Agincourt-Canning, L
    QUALITATIVE HEALTH RESEARCH, 2006, 16 (01) : 97 - 118
  • [34] Ethical implications of predictive DNA testing for hereditary breast cancer
    Di Pietro, ML
    Giuli, A
    Spagnolo, AG
    ANNALS OF ONCOLOGY, 2004, 15 : I65 - I70
  • [35] Clinical evaluation of multigene testing for hereditary breast and ovarian cancer
    Ellisen, Leif
    Kurian, Allison
    Lincoln, Stephen
    Desmond, Andrea
    Mills, Meredith
    Shannon, Kristen
    Gabree, Michelle
    Anderson, Michael
    Kobayashi, Yuya
    Monzon, Federico
    Ford, James
    CANCER RESEARCH, 2015, 75
  • [36] Testing for hereditary breast and ovarian cancer in the southeastern United States
    Miron, A
    Schildkraut, JM
    Rimer, BK
    Winer, EP
    Skinner, CS
    Futreal, PA
    Culler, D
    Calingaert, B
    Clark, S
    Marcom, PK
    Iglehart, JD
    ANNALS OF SURGERY, 2000, 231 (05) : 624 - 632
  • [37] Genetic testing for patients at risk of hereditary breast and ovarian cancer
    DeTroye, Alisha
    Gabbett, Kayla
    Yi, Cheryl
    Judice, Melanie
    Luu, Victor
    Nelson, Brittany
    Gregory, Tanya
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (10): : 48 - 52
  • [38] Technical evaluation of multigene testing for hereditary breast and ovarian cancer
    Lincoln, Stephen
    Kurian, Allison
    Desmond, Andrea
    Nilsen, Geoffrey
    Jacobs, Kevin
    Yang, Shan
    Hart, Reece
    Monzon, Federico
    Ellisen, Leif
    Ford, James
    CANCER RESEARCH, 2015, 75
  • [39] Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations
    Wood, Marie E.
    Garber, Judy E.
    Isaacs, Claudine
    Masood, Shahla
    Bedrosian, Isabelle
    Tung, Nadine
    Chun, Jennifer
    Schnabel, Freya R.
    Arun, Banu K.
    BREAST JOURNAL, 2019, 25 (04): : 575 - 577
  • [40] The changing landscape of genetic testing for hereditary breast and ovarian cancer
    Bellcross, Cecelia A.
    CURRENT PROBLEMS IN CANCER, 2014, 38 (06) : 209 - 215